Clinical trials
Lipids clinical trials
Below are recruiting lipids clinical trials, each written for real people, not researchers. We’re tracking 154 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07478887Recruiting
Corrie Lipids app for better cholesterol management
This study tests a smartphone app called Corrie Lipids to help people with high cholesterol get their LDL levels under control. It may be a good fit if you have high cholesterol that isn't well managed and you have heart disease risk factors like diabetes or a family history.
Baltimore, MarylandAges 18 years+ - NCT07716488Recruiting
Screening for high cholesterol in children with chronic conditions
This study screens children and teens with certain chronic conditions (like heart defects or inflammatory bowel disease) for early signs of high cholesterol or other lipid problems. The goal is to find and manage these risks sooner.
JenaAges 6–18 - NCT07451951Recruiting
Preventing Malnutrition in Infants: Comparing Two Nutrient Supplement Amounts
This study tests whether a small or medium amount of a special nutrient supplement can help prevent malnutrition in babies 6–12 months old. It is for families already in a support program (BISP/BNP) and aims to find the best dose to keep children healthy.
Peshawar, Khyber PakhtunkhwaAges 6 months–8 months - NCT07334834Recruiting
Better cholesterol management for people with artery disease
This study tests a team-based approach to help people with artery disease (like heart attacks or leg blockages) get their cholesterol to a healthier level. If your LDL is above 70, you may benefit from extra support to manage your medications.
Aurora, ColoradoAges 18 years+ - NCT03671044RecruitingPhase 3
Testing a nano-form of docetaxel for triple-negative breast cancer
This Phase 3 study tests whether a special form of docetaxel (a chemotherapy drug) works better and is safe for people with triple-negative breast cancer that has spread or grown locally. You may be eligible if your cancer is triple-negative and you have measurable disease that can be tracked on scans, along with adequate organ and heart function.
Columbus, GeorgiaAges 18–65 - NCT06909929Enrolling by invitation
High-dose IV lipids for very small or early babies
This study tests whether giving a high dose of a special IV fat solution (called lipids) helps very small or very early-born babies grow better. It's for babies weighing under 1500 grams or born before 32 weeks.
Jakarta, Central JakartaAges Up to 7 months - NCT06896708Recruiting
Intensive cholesterol treatment for heart plaque in younger adults
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
Chongqing, Chongqing MunicipalityAges 18–60 - NCT06863545Recruiting
PCSK9 Inhibitors for High-Risk Coronary Plaques on CT
This study tests whether adding a PCSK9 inhibitor (a newer cholesterol-lowering shot) to standard treatment can reduce heart risks in people who have certain high-risk plaque features seen on a CT scan of their heart arteries.
Hangzhou, ZhejiangAges 18 years+ - NCT06388668Recruiting
Lipid testing after a heart attack
This trial looks at cholesterol testing done on the day you are admitted to the hospital after a heart attack. The goal is to learn more about these test results and how they might help guide your care.
Montreal, QuebecAges 18 years+ - NCT05861895RecruitingPhase 1
Study drug HF158K1 for HER2-positive advanced solid tumors
This Phase 1 trial tests HF158K1 in people with advanced solid tumors that have HER2 protein. It aims to see if the drug can be given safely and learn how it works in people whose cancer shows HER2 on tumor testing.
Dallas, TexasAges 18–75 - NCT04212520Recruiting
Using non-fasting cholesterol tests to predict heart events
This study looks at whether cholesterol levels measured without fasting can help predict future heart and blood vessel events in people living in the community. If you join, your non-fasting blood test results may be tracked to see how well they forecast cardiovascular risk.
Guangzhou, GuangdongAges 18 years+ - NCT06383208Recruiting
Heart and kidney risk study for people with both diseases
This study looks at how well we can predict heart and kidney problems in people who have both coronary heart disease and chronic kidney disease. By analyzing certain markers, researchers hope to create a better risk assessment tool.
Beijing, Beijing MunicipalityAges 18–80 - NCT07718048Recruiting
MCT drink study for healthy young adults
This trial tests how different forms of MCT (medium-chain triglyceride) oils affect your body's ketone levels, blood fats, and blood sugar. It is for healthy adults aged 18 to 40 who want to help researchers understand these effects.
MilanAges 18–40 - NCT06625372Recruiting
Comparing two IV nutrition options for children after stem cell transplant
This study compares two types of IV nutrition (Intralipid and SMOF Lipid) for children undergoing stem cell transplants for leukemia. It aims to find which option is better for helping them recover.
TehranAges 2–18 - NCT07685639Recruiting
HEART ATTACK: A study to improve cholesterol care after a heart attack
This trial tests whether a program that uses electronic health records can help people who have had a heart attack lower their LDL (bad) cholesterol more effectively. It aims to improve follow-up care and reduce the risk of future heart problems.
Edmonton, AlbertaAges Any age - NCT07426211Recruiting
Shift work and health effects for hospital staff
This study looks at how shift work affects blood sugar and fat levels in hospital employees. It compares people who work night shifts with those who don't, to see if shift work changes these health markers.
BerlinAges 18–67 - NCT07386249Recruiting
Wheat lipid cream for vaginal dryness in postmenopausal women
This trial tests a cream made from wheat polar lipids to see if it helps with vaginal dryness after menopause. It may offer a non-hormonal option for women with moderate to severe discomfort.
Louvain-la-Neuve, BelgiumAges 45–65 - NCT07388420Recruiting
Adding evolocumab to standard lipid-lowering therapy for hypertriglyceridemia-induced acute pancreatitis
This trial tests if adding a medication called evolocumab to usual cholesterol-lowering treatment helps people who have had a specific type of pancreatitis caused by very high triglycerides (a type of fat in the blood). It aims to reduce triglyceride levels and prevent another episode.
Shenyang, LiaoningAges 18–75 - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65 - NCT07321301RecruitingPhase 2
CAR T-cell therapy for relapsed B-cell lymphoma or leukemia
This trial tests a new type of CAR T-cell therapy for people with B-cell lymphoma or leukemia that has not responded to standard treatments. The therapy uses a special delivery system to help the cells target and kill cancer cells.
Beijing, Beijing MunicipalityAges 14–85 - NCT06878781Recruiting
How your body processes food after a meal
This study looks at how young, healthy adults break down food after eating. It uses blood tests and a metabolic challenge to measure energy use and chemical changes.
Mexico CityAges 18–30 - NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Shanghai, Shanghai MunicipalityAges 18–100 - NCT07143149Recruiting
Smart tool for cholesterol after stroke or mini-stroke
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
BeijingAges 18 years+ - NCT07129109Recruiting
Comparing weekly versus daily nutrition supplement packs for children
This study compares giving the same nutrition supplement in a 7-day package versus a 1-day package to see if one works better for child growth. It is for caregivers of young children in Ghana.
Kumbungu, Northern RegionAges 18 years+
Hear when a new Lipids trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lipids?
- Yes. Clin2 currently lists 154 recruiting lipids studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lipids trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lipids trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.